Remdesivir, tocilizumab helped patients: Study

Remdesivir, tocilizumab helped patients: Study ​The survival rate in patients receiving either or both the drugs was 64%; it dropped to 34% among those who did not get any of the two. In the group that benefitted, the rate of discharge among those given only remdesivir was 66%, for those who got only tocilizumab it was 80%, and 47% among those given both the drugs combined. https://ift.tt/eA8V8J